ALB and hepatocellular carcinoma: Another study conducted by Kim et al. [94] revealed that a high pre-treatment serum ALB–BIL grade was a factor that was independently associated with worse OS and progression-free survival (PFS) in HCC patients treated with proton beam therapy (PBT).